CollPlant Biotechnologies (CLGN) Cash & Equivalents (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Cash & Equivalents of $5.6 million for Q4 2025, down 51.1% on a QoQ basis from $11.4 million in Q2 2025, and down 53.05% year-over-year from $11.9 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Cash & Equivalents (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Cash & Equivalents history runs 9 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- Quarterly Cash & Equivalents fell 53.05% year-over-year to $5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (down 53.05% YoY) and the FY2025 annual result came in at $5.6 million, down 53.05% from the prior year.
- Cash & Equivalents was $5.6 million for Q4 2025 at CollPlant Biotechnologies, down from $11.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $41.3 million in Q1 2022 and bottomed at $5.6 million in Q4 2025.
- A 5-year average of $23.1 million and a median of $24.2 million in 2021 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2021 — Cash & Equivalents soared 397.85% — and 2024, when it slumped 55.35%.
- CollPlant Biotechnologies' Cash & Equivalents stood at $13.1 million in 2021, then soared by 127.14% to $29.9 million in 2022, then fell by 10.68% to $26.7 million in 2023, then slumped by 55.35% to $11.9 million in 2024, then plunged by 53.05% to $5.6 million in 2025.
- Business Quant data shows CLGN's Cash & Equivalents at $5.6 million in Q4 2025, $11.4 million in Q2 2025, and $11.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 440.94 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.59 Mn |
| Jun 30, 2025 | 11.43 Mn |
| Dec 31, 2024 | 11.91 Mn |
| Sep 30, 2024 | 15.37 Mn |
| Jun 30, 2024 | 18.92 Mn |
| Mar 31, 2024 | 26.67 Mn |
| Dec 31, 2023 | 26.67 Mn |
| Sep 30, 2023 | 28.98 Mn |
| Jun 30, 2023 | 22.37 Mn |
| Mar 31, 2023 | 29.86 Mn |
| Dec 31, 2022 | 29.86 Mn |
| Sep 30, 2022 | 32.81 Mn |
| Jun 30, 2022 | 36.50 Mn |
| Mar 31, 2022 | 41.29 Mn |
| Dec 31, 2021 | 13.15 Mn |
| Sep 30, 2021 | 25.97 Mn |
| Jun 30, 2021 | 17.68 Mn |
| Mar 31, 2021 | 19.91 Mn |
| Dec 31, 2020 | 3.53 Mn |
| Sep 30, 2020 | 5.22 Mn |